跳至主要内容
临床试验/TCTR20220810003
TCTR20220810003招募中3 期

Comparison of recurrent biliary obstruction rate among combination of ERCP plus EUS-BD (CERES) in malignant hilar biliary obstruction versus combination of ERCP plus PTBD (CERP): A prospective randomized controlled trial

Excellence Center For GI Endoscopy, King Chulalongkorn Memorial Hospital0 个研究点目标入组 40 人开始时间: 2022年8月10日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • 1. Patients with unresectable malignant biliary hilar obstruction
  • 2. Patients with indication for biliary drainage
  • 3. Patients with good liver area of more than 80%
  • 4. Patients with ECOG score 0-2
  • 5. Patients with expected life expectancy of more than 3 months
  • 6. Patients age 18-90 years
  • 7. Patients who consent to protocol

排除标准

  • 1. Patients with uncorrectable coagulopathy
  • 2. Pregnant patients
  • 3. Patients with marked ascites which interfere with interventions
  • 4. Patients with non-malignant biliary hilar obstruction
  • 5. Patients who can not follow-up longer than 6 months

研究者

发起方
Excellence Center For GI Endoscopy, King Chulalongkorn Memorial Hospital

相似试验

Comparison of recurrent biliary obstruction rate... | 临床试验